- Nachrichtendetail
-
18.06.2024 14:05:04 - dpa-AFX: *LIGAND SAYS MERCK RECEIVES FDA APPROVAL FOR PNEUMOCOCCAL 21-VALENT CONJUGATE VACCINE FOR ADULTS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Merck & Co | A0YD8Q | NYSE | 125,880 | 08.07.24 21:07:50 | -0,570 | -0,45% | 125,880 | 125,900 | 126,800 | 126,450 |
|
Ligand Pharmaceuticals | A1C9RN | NASDAQ | 87,445 | 08.07.24 21:05:34 | +3,075 | +3,64% | 86,850 | 87,600 | 85,890 | 84,370 |
